NFINASE INC

As of September 30, 2011, NFINASE INC carries a market capitalization of 701,310.94, placing it among publicly traded companies globally. Its enterprise value stands at 1.21M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of September 30, 2011, NFINASE INC has 31.88M shares outstanding.

These figures are as of September 30, 2011. The price-to-sales ratio is 0.14, and the price-to-book ratio stands at 0.35.

These figures are as of September 30, 2011. The EV/Sales ratio of 0.26 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 1.21M versus a market cap of 701,310.94, with the gap driven by net debt and cash on the balance sheet.

As of September 30, 2011, NFINASE INC maintains a current ratio of 1.56, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 99.85, indicating elevated leverage, while an interest coverage ratio of -15.97 demonstrates limited ability to service its debt obligations.

Over the twelve months ended September 30, 2011, NFINASE INC posted a negative return on equity (ROE) of -378.51, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -176.60, reflecting losses generated across the asset base. The company generates approximately 66,066.80 in revenue per employee across its workforce of 71.00, a quick read on workforce productivity versus industry peers. Inventory turnover of -5.02 indicates how many times NFINASE INC sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 21, 2026, NFINASE INC's stock has gained approximately 300.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.01.

Over the twelve months ended September 30, 2011, NFINASE INC generated 4.69M in revenue and converted that into -7.92M in net income, yielding earnings per share of -0.27. EBITDA reached -7.27M, while operating income came in at -7.47M.

As of September 30, 2011, NFINASE INC holds 1.52M in cash and equivalents against 2.00M in total debt, resulting in a net debt position of 482,062.00. Total book value stands at 1.98M, with working capital of 1.75M providing operational flexibility.

NFINASE INC produced -8.66M in operating cash flow over the twelve months ended September 30, 2011. After subtracting -104,556.00 in capital expenditures, free cash flow totaled -8.76M - equivalent to -0.30 per share.

Over the twelve months ended September 30, 2011, NFINASE INC posted a gross margin of 147.42, reflecting its pricing power and cost economics. The operating margin of -159.17 and net profit margin of -168.88 provide insight into operational efficiency.

These figures cover the twelve months ended September 30, 2011. The dividend payout ratio of 6.59 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -1,343.96: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -1,189.48, meaning NFINASE INC raised more capital through share issuance and new debt than it returned via dividends and buybacks.

NFINASE INC's most recent stock split took place on December 26, 2006 with a 20:1 split ratio.

As of September 30, 2011, NFINASE INC has an Altman Z-Score of -25.72, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.